Cargando…
Prediction Potential of Serum miR-155 and miR-24 for Relapsing Early Breast Cancer
Oncogenic microRNAs (oncomiRs) accumulate in serum due to their increased stability and thus serve as biomarkers in breast cancer (BC) pathogenesis. Four oncogenic microRNAs (miR-155, miR-19a, miR-181b, and miR-24) and one tumor suppressor microRNA (let-7a) were shown to differentiate between high-...
Autores principales: | Bašová, Petra, Pešta, Michal, Sochor, Marek, Stopka, Tomáš |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666798/ https://www.ncbi.nlm.nih.gov/pubmed/28994735 http://dx.doi.org/10.3390/ijms18102116 |
Ejemplares similares
-
Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
por: Sochor, Marek, et al.
Publicado: (2014) -
Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas
por: Dusílková, Nina, et al.
Publicado: (2017) -
MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia
por: Vargova, K, et al.
Publicado: (2017) -
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019) -
Tai Chi Ameliorates Coronary Heart Disease by Affecting Serum Levels of miR-24 and miR-155
por: Li, Yang, et al.
Publicado: (2019)